West Pharmaceutical Services, Inc. (LON:0ADY)

London flag London · Delayed Price · Currency is GBP · Price in USD
238.10
-18.08 (-7.06%)
At close: Jan 28, 2026
Market Cap12.98B -35.1%
Revenue (ttm)2.25B +4.9%
Net Income365.80M -1.6%
EPS5.02 +0.2%
Shares Outn/a
PE Ratio35.48
Forward PE32.83
Dividend0.64 (0.27%)
Ex-Dividend DateJan 28, 2026
Volume81
Average Volume109
Open238.10
Previous Close256.18
Day's Range238.10 - 238.10
52-Week Range202.60 - 321.43
Betan/a
RSI41.26
Earnings DateFeb 12, 2026

About LON:0ADY

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhanc... [Read more]

Industry Fabricated Rubber Products, Not Elsewhere Classified
Founded 1923
Employees 10,600
Stock Exchange London Stock Exchange
Ticker Symbol 0ADY
Full Company Profile

Financial Performance

In 2024, LON:0ADY's revenue was $2.89 billion, a decrease of -1.92% compared to the previous year's $2.95 billion. Earnings were $492.70 million, a decrease of -16.97%.

Financial numbers in USD Financial Statements